Considering the fact that the hyperinsulinemia induced by obesity-linked systemic insulin resistance causes glucose intolerance and hepatic steatosis, simple glycemic control by insulin administration or use of medications to stimulate the insulin secretion is likely to improve the blood glucose levels, but will fail to improve the hepatic steatosis. The gene discussed is INS; the disease is fatty liver disease.